Position in ANIP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,987,341
+$2,516,591 QoQ
Shares Held
108,569
+29.0% QoQ
Ownership
0.473%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#53
of 303 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GLOBEFLEX CAPITAL L P holds $37,103,577 across 12 Drug Manufacturers - Specialty & Generic names. ANIP ranks #1 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
This page
|
108,569 | $8,987,341 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
93,396 | $5,972,674 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
189,224 | $5,941,633 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
28,363 | $4,780,300 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
146,508 | $2,536,053 | |
| 6 | EBS |
Emergent BioSolutions Inc.
|
241,298 | $2,022,077 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
52,911 | $1,915,378 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
|
87,600 | $1,281,588 |
All Filings in ANIP
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,987,341 | 108,569 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,470,750 | 84,145 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,370,197 | 55,361 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,803,326 | 30,604 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $691,454 | 10,597 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $709,469 | 10,597 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $585,802 | 10,597 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $632,217 | 10,597 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $674,816 | 10,597 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $805,295 | 11,649 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $711,636 | 12,906 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $749,322 | 12,906 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $355,278 | 6,600 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $616,143 | 21,919 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,010,027 | 21,919 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $719,381 | 21,919 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $768,260 | 21,919 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $792,152 | 21,919 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $636,527 | 21,919 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,162,590 | 41,212 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,276,039 | 39,457 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,554,434 | 38,155 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||